FILE PHOTO: Vials of Eli Lilly's Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and weigh loss, are ...

One of the world’s biggest drugmakers has halted the sale of weight-loss jabs to the UK as patients race to beat a looming ...

The drug's US manufacturer has asked UK distributors to stop taking orders from pharmacies until next month's price increase.

Although data for Eli Lilly’s orforglipron may have disappointed investors earlier this month, a new release of Phase III ...

The obesity-care market is largely dominated by just two players: Eli Lilly and Novo Nordisk. 10 stocks we like better than ...

Shares of Chugai Pharmaceutical (OTCPK:CHGCY) closed ~6% higher on Wednesday after Eli Lilly (NYSE:LLY) announced that its ...

The bear case for Eli Lilly has now played out following the reaction to the drugmaker’s oral obesity drug trial, an analyst ...

Eli Lilly has temporarily halted UK shipments of its weight-loss drug Mounjaro ahead of a significant price increase set for ...

Reflecting this potential, Goldman Sachs analyst Asad Haider on August 15 reiterated a Buy rating on Eli Lilly and Company ...

Altimmune, Inc.'s pemvidutide shows promise in weight loss and MASH but faces challenges. Click for my updated look at ALT ...

Analysts have set 12-month price targets for Eli Lilly, revealing an average target of $923.11, a high estimate of $1135.00, and a low estimate of $700.00. Observing a downward trend, the current ...